Clinical Trials Logo

Osgood-Schlatter Disease clinical trials

View clinical trials related to Osgood-Schlatter Disease.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05174182 Active, not recruiting - Clinical trials for Osgood-Schlatter Disease

A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter

SOGOOD
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The most common growth-related injury is Osgood Schlatter, which affects up to 1 in 5 physically active adolescents. It can cause long-term pain and potential discontinuation of sports and physical activity, with sequela well into adulthood. No effective conservative treatments have been documented, and clinical practice is characterized by a wealth of conflicting advice and modalities. A novel treatment approach has shown promising results in a small single-cohort study. Therefore, this study aims to compare this novel treatment with usual care in 10-16-year-old adolescents with Osgood Schlatter. This single-center pragmatic, double-blinded, randomized, controlled superiority trial, will have a two-group parallel arm design. Participants will undergo 3 months of treatment, followed by 2 months of self-management with self-reported knee function (KOOS-child 'Sport/rec') at 5 months as the primary endpoint. This trial comparing a novel treatment with usual care for adolescents with Osgood Schlatter could result in an evidence-based treatment ready for implementation in clinical practice, benefitting patients outcomes and clinicians.